Analysts Set The Chemours Company (NYSE:CC) Target Price at $30.89

Shares of The Chemours Company (NYSE:CC) have been assigned an average recommendation of “Hold” from the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $30.89.

Several equities analysts recently issued reports on the stock. UBS Group boosted their target price on shares of Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a research note on Tuesday, April 2nd. BMO Capital Markets raised shares of Chemours from an “underperform” rating to an “outperform” rating and boosted their price target for the stock from $19.00 to $34.00 in a report on Tuesday, April 9th. Finally, Barclays dropped their target price on shares of Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a report on Tuesday, April 2nd.

Institutional Trading of Chemours

Several hedge funds have recently made changes to their positions in CC. Hexagon Capital Partners LLC purchased a new stake in shares of Chemours during the fourth quarter worth approximately $25,000. Legacy Financial Group LLC acquired a new stake in Chemours in the third quarter valued at $29,000. Morton Brown Family Wealth LLC acquired a new stake in Chemours in the fourth quarter valued at $35,000. Neo Ivy Capital Management acquired a new stake in Chemours in the fourth quarter valued at $40,000. Finally, Sunbelt Securities Inc. increased its position in shares of Chemours by 1,969.7% in the first quarter. Sunbelt Securities Inc. now owns 1,366 shares of the specialty chemicals company’s stock valued at $36,000 after buying an additional 1,300 shares in the last quarter. Institutional investors and hedge funds own 76.26% of the company’s stock.

Chemours Stock Down 0.2 %

CC stock opened at $27.03 on Tuesday. The firm has a 50 day moving average of $26.73 and a 200 day moving average of $27.80. The stock has a market capitalization of $4.02 billion, a PE ratio of -17.44 and a beta of 2.00. The company has a quick ratio of 1.00, a current ratio of 1.54 and a debt-to-equity ratio of 5.40. Chemours has a 52 week low of $15.10 and a 52 week high of $39.05.

Chemours (NYSE:CC) last announced its quarterly earnings data on Wednesday, March 27th. The specialty chemicals company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.29 by $0.02. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. The business had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Sell-side analysts forecast that Chemours will post 2.23 earnings per share for the current year.

Chemours Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were given a $0.25 dividend. The ex-dividend date was Friday, February 23rd. This represents a $1.00 dividend on an annualized basis and a yield of 3.70%. Chemours’s payout ratio is currently -64.52%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.